E. Bolli

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil

R. Rosso, A. Sobrero, S. Bertoglio, 2004, Cancer Chemotherapy and Pharmacology.

5-Fluorouracil may have different mechanisms of action depending on the dose schedule: clinical implications

J. Bertino, R. Rosso, A. Sobrero, 1994 .

Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.

R. Rosso, G. Rollandi, S. Mammoliti, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dacarbazine and fotemustine in advanced colorectal cancer.

R. Rosso, A. Sobrero, A. Guglielmi, 1993, European journal of cancer.

5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer

R. Rosso, A. Sobrero, B. Ligas, 1995, Cancer Chemotherapy and Pharmacology.

Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.

P. Bruzzi, A. Sobrero, L. Gallo, 1992, European journal of cancer.

Standard indication of immunotherapy for the treatment of cancer.

A. Sobrero, E. Rovini, A. Guglielmi, 1992, Pharmacological research.